Personally, I am not that interested in the financials at this stage. It is too early in the commercialization stage to be really meaningful; in my opinion anyway.
We know POET has just had a large cash injection with another salvo of cash coming soon from the warrants.
So cash flow is a non-issue.
I am more interested in the MD&A content and more commercial InP related NR's and hopefully ISRO.
It appears to me that the optics on POET will soon be mind blowingly exciting.
Just a little more time now.
Sit back, relax and let the POET Team execute.
POET 2018.